Berlin RG - Search Results

1

Prolonged inhibition of acid secretion causes hypergastrinaemia without altering pH inhibition of gastrin release in humans.

Karnes WE, Berlin RG, Maxwell V, Sytnik B, Root JK, Walsh JH. Karnes WE, et al. Among authors: berlin rg. Aliment Pharmacol Ther. 1990 Oct;4(5):443-56. doi: 10.1111/j.1365-2036.1990.tb00491.x. Aliment Pharmacol Ther. 1990. PMID: 2129633 Clinical Trial.

2

Nocturnal therapy with famotidine for 1 year is effective in preventing relapse of gastric ulcer.

Berlin RG, Root JK, Cook TJ. Berlin RG, et al. Aliment Pharmacol Ther. 1991 Apr;5(2):161-71. doi: 10.1111/j.1365-2036.1991.tb00017.x. Aliment Pharmacol Ther. 1991. PMID: 1888817 Clinical Trial.

3

U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study Group.

Valenzuela JE, Berlin RG, Snape WJ, Johnson TL, Hirschowitz BI, Colon-Pagan J, Morse RS, Petrozza J, Van Deventer GM, Cagliola A, et al. Valenzuela JE, et al. Among authors: berlin rg. Dig Dis Sci. 1991 Jun;36(6):761-8. doi: 10.1007/BF01311234. Dig Dis Sci. 1991. PMID: 2032518 Clinical Trial.

4

Randomized, placebo-controlled comparison of famotidine 20 mg b.d. or 40 mg b.d. in patients with erosive oesophagitis.

Simon TJ, Berenson MM, Berlin RG, Snapinn S, Cagliola A. Simon TJ, et al. Among authors: berlin rg. Aliment Pharmacol Ther. 1994 Feb;8(1):71-9. doi: 10.1111/j.1365-2036.1994.tb00162.x. Aliment Pharmacol Ther. 1994. PMID: 8186349 Clinical Trial.

5

Omeprazole. Gastrin and gastric endocrine cell data from clinical studies.

Berlin RG. Berlin RG. Dig Dis Sci. 1991 Feb;36(2):129-36. doi: 10.1007/BF01300745. Dig Dis Sci. 1991. PMID: 1988254 Review.

6

Gastrointestinal safety and tolerance of ibuprofen at maximum over-the-counter dose.

Doyle G, Furey S, Berlin R, Cooper S, Jayawardena S, Ashraf E, Baird L. Doyle G, et al. Aliment Pharmacol Ther. 1999 Jul;13(7):897-906. doi: 10.1046/j.1365-2036.1999.00539.x. Aliment Pharmacol Ther. 1999. PMID: 10383524 Clinical Trial.

7

Acid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitis.

Simon TJ, Roberts WG, Berlin RG, Hayden LJ, Berman RS, Reagan JE. Simon TJ, et al. Among authors: berlin rg. Clin Ther. 1995 Nov-Dec;17(6):1147-56. doi: 10.1016/0149-2918(95)80093-x. Clin Ther. 1995. PMID: 8750406 Clinical Trial.

8

Efficacy of twice daily doses of 40 or 20 milligrams famotidine or 150 milligrams ranitidine for treatment of patients with moderate to severe erosive esophagitis. Famotidine Erosive Esophagitis Study Group.

Simon TJ, Berlin RG, Tipping R, Gilde L. Simon TJ, et al. Among authors: berlin rg. Scand J Gastroenterol. 1993 May;28(5):375-80. doi: 10.3109/00365529309098235. Scand J Gastroenterol. 1993. PMID: 8511496 Clinical Trial.

9

Self-Directed Treatment of Intermittent Heartburn: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Evaluation of Antacid and Low Doses of an H(2)-Receptor Antagonist (Famotidine).

Simon TJ, Berlin RG, Gardner AH, Stauffer LA, Gould AL, Getson AJ. Simon TJ, et al. Among authors: berlin rg. Am J Ther. 1995 May;2(5):304-313. Am J Ther. 1995. PMID: 11850668

10

Omeprazole: gastrin and gastric data (August 1991).

Berlin RG. Berlin RG. Dig Dis Sci. 1991 Oct;36(10):1501-2. doi: 10.1007/BF01296825. Dig Dis Sci. 1991. PMID: 1914779 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters